是永匡紹 (Korenaga Masaaki) - MISC

MISC

表示件数

MULTI-CENTER AND PROSPECTIVE COHORT STUDY OF 599 JAPANESE PATIENTS WITH HCV GENOTYPE 1 INFECTION REVEALS SUSTAINED VIROLOGICAL RESPONSE BY LEDIPASVIR/SOFOSBUVIR REDUCES THE INCIDENCE OF HEPATOCELLULAR CARCINOMA AS SAME AS PEG-INTERFERON PLUS RIBAVIRIN

Masaaki Korenaga, Namiki Izumi, Nobuharu Tamaki, Osamu Yokosuka, Tatsuo Kanda, Tetsuo Takehara, Naoya Sakamoto, Goki Suda, Shuhei Nishiguchi, Hirayuiki Enomoto …

HEPATOLOGY 70 368A-369A 2019年10月
DAA治療予後と残された課題 SVR後発がんとHCV陽性者の撲滅

是永匡紹, 榎本大, 是永圭子, 横須賀收, 井出達也, 井上貴子, 日高勲, 柿崎暁, 小林良正, 本田浩一 …

肝臓 60(Suppl.1) A386-A386 2019年4月
The Risk of Hepatocellular Carcinoma Development after Sustained Virologic Response Are Similar between Japanese Patients with HCV Genotype 1 Infection Treated with Ledipasvir/Sofosbuvir and Protease Inhibitor with Peg-Interferon Plus Ribavirin.

Masaaki Korenaga, Namiki Izumi, Nobuharu Tamaki, Osamu Yokosuka, Tetsuo Takehara, Naoya Sakamoto, Goki Suda, Shuhei Nishiguchi, Hirayuki Enomoto, Fusao Ikeda …

HEPATOLOGY 68 535A-536A 2018年10月
A Prognostic Impact of an Activator of Tumor-Associated Macrophages, Interleukin-34, in Patients with Non-Viral Hepatocellular Carcinoma: A Data-Mining Analysis

Yu Noda, Takumi Kawaguchi, Masaaki Korenaga, Sachiyo Yoshio, Sho Komukai, Masahito Nakano, Takashi Niizeki, Hironori Koga, Atsushi Kawaguchi, Tatsuya Kanto …

HEPATOLOGY 68 844A-844A 2018年10月
CXCL13/IL-21誘導はB型急性・慢性肝炎患者のHBs抗原陰性化に寄与する

由雄祥代, 河合裕成, 坂本譲, 島垣智成, 青木孝彦, 土肥弘義, 大澤陽介, 是永匡紹, 考藤達哉

肝臓 59(Suppl.2) A658-A658 2018年9月
NAFLD患者における体組成および肝脂肪・肝硬度を指標とした栄養食事療法と運動療法の併用効果に関する検討

古田雅, 是永匡紹, 青木孝彦, 宮内真佑子, 味原美里, 嶋悠也, 吾妻導人, 玉田良樹, 濱崎秀崇, 柳内秀勝 …

日本病態栄養学会誌 21(Suppl.) S-110 2018年1月
Hepatocellular carcinoma development in Japanese patients with HCV genotype 1 infection who achieved sustained virologic response by ledipasvir/sofosbuvir and protease inhibitor with peginterferon plus ribavirin

Masaaki Korenaga, Namiki Izumi, Osamu Yokosuka, Tetsuo Takehara, Naoya Sakamoto, Shuhei Nishiguchi, Fusao Ikeda, Mikio Yanase, Hidenori Toyoda, Takuya Genda …

HEPATOLOGY 66 563A-564A 2017年10月
A Prognostic Impact of Fibroblast-derived Cytokine, IL-34 in Non-hepatitis B virus-, Non-hepatitis C virus-related Hepatocellular Carcinoma Patients with Chronic Liver Disease

Yu Noda, Takumi Kawaguchi, Masaaki Korenaga, Masahito Nakano, Takashi Niizeki, Hironori Koga, Tatsuya Kanto, Takuji Torimura

HEPATOLOGY 66 732A-732A 2017年10月
Low incidence of HBV reactivation and consequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy

Akihiro Tamori, Seigo Abiru, Hirayuki Enomoto, Kiyohide Kiyoka, Masaaki Korenaga, Joji Tani, Masaru Enomoto, Masaya Sugiyama, Tutomu Masaki, Norifumi Kawada …

HEPATOLOGY 66 989A-990A 2017年10月
Roles of designated hepatologists on treatment of chronic hepatitis C patients with directly-acting antivirals: Evidences based on nation-wide, real-world database in Japan

Naohiko Masaki, Mikio Yanase, Yuichi Nozaki, Shintaro Mikami, Masaaki Korenaga, Tatsuya Kanto

HEPATOLOGY 66 822A-822A 2017年10月
Deferasirox prevents progression of non-alcoholic steatohepatitis in a mouse model with inhibition of heaptic fibrosis and hepatocellular ballooning

Masaaki Korenaga, Keiko Korenaga, Masashi Mizokami, Tatsuya Kanto

HEPATOLOGY 64 785A-786A 2016年10月
Effects of interferon-free treatment on serum cholesterol levels are different between the two sofosbuvir-based regimens in chronic HCV-infected patients

Naohiko Masaki, Masaaki Korenaga, Mikio Yanase, Yuichi Nozaki, Shintaro Mikami, Yoshihiko Aoki, Masatoshi Imamura, Kazumoto Murata, Tatsuya Kanto, Masashi Mizokami

HEPATOLOGY 64 981A-981A 2016年10月
Comprehensive understanding of associations between HLA class II genes and chronic hepatitis B infection in the Japanese population

Nao Nishida, Jun Ohashi, Masaya Sugiyama, Hiromi Sawai, Keisuke Hino, Masao Honda, Shuichi Kaneko, Hiroshi Yatsuhashi, Osamu Yokosuka, Kazuhiko Koike …

HEPATOLOGY 64 311A-311A 2016年10月
Serum YKL-40 as a marker of liver fibrosis and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

Yohei Mano, Erina Kumagai, Hirotaka Shoji, Sachiyo Yoshio, Masaya Sugiyama, Masaaki Korenaga, Taeang Arai, Norio Itokawa, Masanori Atsukawa, Hideyuki Hyogo …

HEPATOLOGY 64 799A-799A 2016年10月
Association of skin capsular distance with accuracy of liver stiffness measurements of the FibroScan XL probe-comparison with virtual touch quantification and the FibroScan M probe

Erina Kumagai, Keiko Korenaga, Masaaki Korenaga, Misuzu Ueyama, Yoshihiko Aoki, Yoko Yamagiwa, Masatoshi Imamura, Kazumoto Murata, Tatsuya Kanto, Naohiko Masaki …

HEPATOLOGY 62 605A-605A 2015年10月
Distribution of pre-existing NS5A/NS5B resistance associated variants in genotype 1b patients with hepatitis C virus and response to direct acting antivirals

Takeshi Watabe, Masaaki Korenaga, Masaya Sugiyama, Erina Kumagai, Misuzu Ueyama, Yoshihiko Aoki, Yoko Yamagiwa, Keiko Korenaga, Masatoshi Imamura, Kazumoto Murata …

HEPATOLOGY 62 1083A-1083A 2015年10月
Impact of toll-like receptor 4 signaling on liver fibrosis in uPA/SCID mice with human hepatocytes persistently infected with hepatitis B virus

Masaya Sugiyama, Tatsuya Kanto, Masaaki Korenaga, Kazumoto Murata, Naohiko Masaki, Masashi Mizokami

HEPATOLOGY 62 1017A-1017A 2015年10月
Usefulness of mac-2 binding protein glycosylation isomer (M2BPGi) for advanced fibrosis and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

Erina Kumagai, Masaaki Korenaga, Keiko Korenaga, Misuzu Ueyama, Masatoshi Imamura, Masaya Sugiyama, Kazumoto Murata, Naohiko Masaki, Tatsuya Kanto, Sumio Watanabe …

HEPATOLOGY 62 1277A-1277A 2015年10月
Association between severe rash and HLA polymorphism in telaprevir-based triple therapy for chronic hepatitis C in a multi-centric study in Japan

Yoko Yamagiwa, Naohiko Masaki, Nao Nishida, Minae Kawashima, Seik-Soon Khor, Hiroko Miyadera, Masaya Sugiyama, Masaaki Korenaga, Kazumoto Murata, Tatsuya Kanto …

HEPATOLOGY 62 771A-771A 2015年10月
PNPLA3 and JAZF1 variants influence hepatocellular carcinoma development in non-viral hepatitis patients with type 2 diabetes patients

Misuzu Ueyama, Masaaki Korenaga, Nao Nishida, Keiko Korenaga, Erina Kumagai, Masaya Sugiyama, Yoshihiko Aoki, Masatoshi Imamura, Kazumoto Murata, Naohiko Masaki …

HEPATOLOGY 62 1259A-1260A 2015年10月

マイポータルへ